BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lissoni P, Bonfanti A, Bordin V, Barni S, Vigore L, Ferrante R, Rovelli F, Fumagalli L. Changes in Circulating Immature and Mature Dendritic Cells During IL-2 Cancer Immunotherapy and Their Relation with Lymphocyte Increase and Clinical Response. Hematology 2016;5:117-25. [DOI: 10.1080/10245332.2000.11746494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Osada T, Clay TM, Woo CY, Morse MA, Lyerly HK. Dendritic cell-based immunotherapy. Int Rev Immunol. 2006;25:377-413. [PMID: 17169781 DOI: 10.1080/08830180600992456] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 4.8] [Reference Citation Analysis]
2 Mosca PJ, Clay TM, Kim Lyerly H, Morse MA. CURRENT STATUS OF DENDRITIC CELL IMMUNOTHERAPY OF MALIGNANCIES. International Reviews of Immunology 2009;22:255-81. [DOI: 10.1080/08830180305223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]